5 nov 2019
CPhI Worldwide 2019
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD

BDR PHARMACEUTICALS INTERNATIONAL PVT LTD

Exhibitor at CPhI Worldwide 2019 stand 91C50, Finished Dosage Formulations

About us

BDR is a niche player for introduction of a number of critical molecules over the years. We are specialized in early identification, development and introduction of fifth generation medicines for life threatening diseases, producing both APIs and Finished Formulations through continuous and rigorous research.At BDR, innovation lies at the heart of every new concept, and forms the fuel that drives us to improve upon our best every day. Our innovative and new age methodologies inculcate novel delivery systems for existing molecules and optimize on the existing formulations, thereby improving on the standards and quality of therapy. We have carried out successful developments like Liposomal delivery systems, Microspheres, Depot formulations, Pegylated delivery systems and other complicated formulations. Apart from working in the local and developing markets until now, we are now fully focused on emerging as well as regulated markets with an all-round preparedness in terms of setting up of world class R&D, regulatory team which is well versed with evolving regulatory requirements of such demanding markets.
BDR Group focuses on development in 5 specialized therapeutic segments, viz. Oncology, Critical care, Gynaecology, Neurology & Dermatology which are its focus segments.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Intermediates, Fine and Specialty Chemicals |Finished Dosage Forms |APIs More
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 91C50